GSK3B and Parkinson disease: Taken together, these data indicate that GSK-3β and mTOR are likely two common denominators that link metabolic dysfunction with weight loss and neurodegeneration, and thus offer a molecular basis for the association between weight loss and disease severity seen in PD patients10.